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Transcription factors controlling B-cell development
Two structurally dissimilar transcriptional regulators, E2A and Pax-5,
have been shown to play essential roles in B-cell development; the p50
subunit of NFKB, by contrast, is required for normal immune responses.
B-lymphocyte development has long been studied
because of its unique biological objectives, which include
the generation of immunoglobulin diversity and the
shaping of the antibody repertoire. B lymphopoiesis, like
all other developmental processes, entails the ordered,
sequential expression of specific sets of structural and reg-
ulatory genes. A sizable body of work - mostly correla-
tive - has implicated a diverse group of regulatory
proteins as important for the regulation of gene expres-
sion during B-cell development. Nonetheless, direct
assessment of the roles of individual transcription factors
has only recently been made possible by the targeted dis-
ruption of specific genes in mice. In the past several
months, this approach has been used to test the depen-
dence of B-cell development on three structurally dissim-
ilar transcription factors - E2A [1,2], Pax-5 [3] and the
p50 subunit of NFKB [4] - whose involvement in B-
cell development had been indicated by previous work.
The E2A gene encodes a pair of closely related proteins,
E12 and E47, which are generated by alternative splicing
of RNA transcripts [5]. The E2A proteins, and the prod-
uct of a homologous gene called E2-2, were first iden-
tified by their ability to bind a class of specific consensus
DNA sites, the E2 motifs, which are found in the
intronic immunoglobulin p. and K enhances. E2 and
related motifs (collectively termed E-boxes) were defined
by in vivo footprinting of the proteins bound at sites
in the intronic immunoglobulin heavy chain enhancer
that are occupied specifically in lymphoid cells. Similar
sequence elements were subsequently found in all imm-
unoglobulin enhancers and in several regulatory regions
that are active in non-lymphoid settings, including the
muscle creatine kinase enhancer and the insulin promoter.
Mutational analysis has shown that the E-boxes, and the
E2 motifs in particular, are critical for immunoglobulin
enhancer function.
E12, E47 and E2-2 are members of the basic
helix-loop-helix (bHLH) family of transcription factors.
These proteins share two characteristic structural features:
a pair of amphipathic helices, separated by a loop of vari-
able length (the helix-loop-helix or HLH region); and
an adjacent, conserved basic region. The bHLH proteins
bind to DNA as homo- or heterodimers; in addition to
dimerization, which is mediated by the HLH region,
DNA binding requires the basic region. Some bHLH
proteins, including E12, E47 and E2-2, are expressed
ubiquitously. Others are expressed in a tissue-specific
fashion; these include the MyoD family, which is
required for muscle development, and the Achaete-Scute
family, which functions in neurogenesis.
The ability of bHLH proteins to form heterodimers pro-
vides a potentially rich source of combinatorial diversity
- distinct bHLH dimers show dramatic differences in
DNA binding. For example, the non-tissue-specific
bHLH proteins can bind the E2 motif as homodimers, as
heterodimers with each other, or as heterodimers with
tissue-specific bHLH proteins. In contrast, tissue-specific
bHLH proteins bind the E2 motif only as heterodimers
with non-tissue-specific proteins. In the B-cell lineage,
the predominant E2-binding activities are contributed by
the E2A proteins and E2-2.
Several observations have suggested that B-cell develop-
ment might be critically dependent on E2A (and perhaps
E2-2). A specific E2 site, p.E5, which is situated within
the immunoglobulin ,u intronic enhancer, acts as a positive
transcriptional element in lymphoid cells and a suppressor
of immunoglobulin transcription in non-lymphoid cells.
E12 and E47 can activate the intronic enhancer when
cotransfected with a reporter construct into non-B cells
[6]. Furthermore, overexpression of E47 can induce tran-
scription and rearrangement of endogenous immuno-
globulin heavy-chain genes in pre-T cells [7]. Curiously,
despite the presence of E2A proteins in other cell types,
only extracts of B-lymphoid cells have yielded E2A
homodimers capable of binding to the E2 motif [8,9].
Nonetheless, until the recent 'gene knockout' experi-
ments, an essential role for E2A in B-cell development
was far from certain. Indeed, targeted disruption of the
E2A gene, despite its broad expression pattern, had no
effect on the ability of cultured embryonic stem cells to
differentiate into muscle, cartilage, nerve or erythroid
lineages [10]. In this context, the effect of E2A inactiva-
tion on murine B-cell development, described recently
by two independent teams, is especially striking. The
approaches of the two groups differed somewhat but the
results are similar overall. Zhuang and coworkers [2]
effected a complete knockout of both E2A products. In
contrast, Bain and coworkers [1] selectively disrupted the
E12-coding sequence; for reasons that are not entirely
clear, this also interfered with expression of E47. In
either case, homozygous E2A-deficient mice exhibited a
profound block in B-cell development.
On the basis of immunoglobulin expression, developing
B cells can be divided into three broad groups: pro-B
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cells, in which no immunoglobulin chains are expressed;
pre-B cells, in which immunoglobulin pl heavy chains,
but not light chains, are expressed; and B cells, in which
immunoglobulin heavy and light chains are expressed at
the cell surface. These stages reflect the underlying
sequence of immunoglobulin gene rearrangements -
light chains are generally (but not necessarily) assembled
after heavy chains. Immunoglobulin heavy chain gene re-
arrangement occurs in a CD45R+ c-kit+ CD25+ CD43+
population (termed proB/pre-B-I by Melchers and co-
workers [11]); upon productive heavy chain gene re-
arrangement these cells give rise to a CD45R+ c-kit-
CD25+ population (large pre-B-II), which is heteroge-
neous with respect to CD43 expression. Large preB-II
cells subsequently give rise to a resting, CD43- popula-
tion (small pre-B-II), in which most immunoglobulin
light-chain gene rearrangement occurs (Fig. 1).
B cells are absent from the spleens of homozygous
E2A-deficient (E2A-/ -) mice, and in bone marrow the
percentage of CD45R+ CD43- cells is reduced at least
ten-fold. This is consistent with a block in development
at or before the transition from pro-B/pre-B-I cells to
large pre-B-II cells (Fig. 1). Immunoglobulin gene re-
arrangements are undetectable in the fetal liver or bone
marrow of E2A- / - mice, indicating a failure of B-cell
development to progress to the pre-B cell stage. Interest-
ingly, B-cell development is blocked at a similar stage in
immunoglobulin heavy chain deficient mice, and in mice
carrying homozygous disruptions of the recombination
activating genes, RAG-1 or RAG-2 [12,13]. In contrast,
the effect of E2A disruption on T-cell development
seems to be minimal. Modest alterations in the ratios
of intrathymic T-lymphoid subsets are observed in
E2A-/ - mice, beginning several weeks after birth. These
changes may, however, be a secondary effect of the
B-cell deficiency.
What is the nature of the E2A requirement at this devel-
opmerital stage? The available evidence is consistent with
possible effects on transcription and immunoglobulin
gene rearrangement. Several B-lineage-specific tran-
scripts, including those for RAG-1 and the transcrip-
tional activator pax-5, are substantially reduced in E2A- / -
mice [1]. Assuming that the absence of these transcripts
does not merely reflect reduced cell number (which
remains a possibility), diminished expression of these
genes - and perhaps others - could contribute to the
observed developmental defect. As an example of the
possible ramifications of E2A inactivation, consider Pax-
5, itself a transcription factor whose production in adult
mice is restricted to the B lineage and testes [14]. Pax-5
has been implicated as a positive regulator of several B-
cell-specific genes. Remarkably, homozygous disruption
of the pax-5 gene results in a B-lymphoid developmental
arrest similar to that seen in E2A knockout mice: B
cells are absent or greatly diminished, and large
CD45R + CD43+ B-cell progenitors are detectable in the
bone marrow but fail to progress to the small CD43-
stage [3]. In contrast to the E2A-/ - mice, the pax-5
knockout mice exhibit a low but detectable level of
immunoglobulin p, gene rearrangements, suggesting that
Pax-5 normally acts downstream of E2A. Nonetheless, it
remains possible that diminished expression of pax-5 plays
a role in determining the E2A-deficient phenotype.
A link between the inactivation of E2A and failure to
rearrange immunoglobulin genes could stem from effects
on the production of RAG proteins, which are essential
for immunoglobulin gene assembly, or on the accessibil-
ity of the immunoglobulin heavy chain locus to the
recombinase machinery. As the transcription and assem-
bly of immunoglobulin genes share common elements of
control, E2A might normally potentiate rearrangement
through its effects on the heavy chain intronic enhancer.
In normal mice, unrearranged heavy chain loci give rise
to two transcripts, pxo and I , which are initiated
upstream of the JH cluster and within the intronic
immunoglobulin p. enhancer, respectively. In the fetal
livers of E2A- /- mice, pLo and I transcripts are both
Fig. 1. Blockade of B-cell development
by inactivation of the E2A or pax-5
genes. B-cell developmental stages are
depicted according to the nomenclature
of Melchers and coworkers [11]. Devel-
opmental blocks associated with inacti-
vation of Ikaros (Ikaros-/-), E2A (E2A-/-),
RAG-1 or RAG-2 (RAG- - ) and pax-5
(pax-5-/-) are indicated. The position of
the E2A- /- developmental block is based
on the absence of immunoglobulin
heavy chain gene rearrangements and
CD45R+CD43- bone marrow cells in
homozygous E2A-deficient mice. The
position of the pax-5-/- effect is less
clear; the published data are consistent
with a developmental block at the tran-
sition from pro-B/pre-B-l cells to large
pre-B-ll cells, or within the large pre-B-ll
stage.
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reduced but the reduction in I RNA is far greater, sug-
gesting that E2A proteins are specifically required for I,
transcription [1]. As the transcription of immunoglobulin
loci is correlated with their ability to undergo rearrange-
ment, the lack of I transcription may also reflect inac-
cessability of the immunoglobulin IX locus to the
recombinase machinery; in this scheme, the resulting
failure to express immunoglobulin pI would be an imme-
diate cause of the developmental block.
Remarkably, heterozygous E2A+/- embryos have about
half as many B-lymphoid cells in their fetal livers as wild-
type littermates [2]. In principle, random inactivation of
one E2A allele could produce such a phenotype, but this
mechanism is considered unlikely because in transgenic
animals the E2A promoter remains active in the majority
of B cells [2]. Positive autoregulation of E2A expression
could also provide an explanation, but this also seems
unlikely because E2A RNA levels seem to correspond to
gene dosage. Zhuang and coworkers [2], rather, favor a
threshold effect, effected by the inhibitory proteins Idl
or Id2, which are normally expressed in pro-B cells but
which are down-regulated later in B-cell development.
The Id proteins form inactive heterodimers with bHLH
proteins [15]; thus, if Idl or Id2 were to mop up any
E2A protein below a certain threshold level, this could
account for the observations in E2A+/- heterozygotes.
The ability of Idl to interfere with E2A function is
underscored by an experiment in which constitutive Idl
gene expression was targeted to the B lineage in trans-
genic mice [16]. Under these conditions, B-cell develop-
ment fails to progress to the CD45R+ CD43- pre-B-cell
stage - a defect reminiscent of the E2A-deficient
phenotype and consistent with inhibition of E2A by Idl.
Although the most striking effect of E2A inactivation is
the B-cell developmental block, an additional defect is
observed in E2A- / - mice - an apparent failure to thrive
[2]. Among progeny of crosses between E2A+/- mice,
Zhuang and colleagues [2] observed that homozygous
E2A- / - progeny were represented normally (about 1/4) in
embryos at embryonic day 18.5, but were under-repre-
sented (about 1/10) by one week of age. Postnatal death
in E2A- / - mice is accompanied by cessation of growth,
weight loss and dehydration. The differential rate of
growth between homozygous and heterozygous litter-
mates is apparently not a result of a failure to feed, nor
does the B-cell deficiency alone seem to be responsible, as
sterile care did not overcome this defect. Nonetheless,
E2A is clearly inessential for determination of most cell
types and for embryonic development. The results are
consistent with compensatory effects in those processes for
which E2A is not essential (perhaps through the action of
homologous genes such as E2-2), and imply that a lack of
E2A cannot be compensated for in the B lineage.
In contrast, inactivation of the p50 component of the
NFKB transcription factor illustrates that the phenotypes
of knockout mice cannot be predicted from in vitro
studies [4]. NFKB is a ubiquitous, heterodimeric factor
comprising p50 and p65 subunits. Despite its broad
expression pattern, NFKB DNA-binding activity is unde-
tectable in most cell types. A low level of constitutive
activity is detectable in B-lymphoid cells, however, and
this activity is substantially increased in response to a vari-
ety of stimuli, including exposure to bacterial lipopolysac-
charide and engagement of surface immunoglobulin.
Induction of NFKB activity involves dissociation of the
p50-p65 heterodimer from an inhibitor, IKB, and translo-
cation of the heterodimer to the nucleus. Target genes
that are regulated by NFkB include those for
immunoglobulin K, the type I and II major histocompati-
bility complex proteins and a number of cytokines
(including IL-1 3, IL-2, IL-6, IFN-[3 and TNF-o).
NFKB is one of several related transcription factors that
can be assembled from products of the NFKB/rel gene
family. This family includes NFKB-1 (encoding the p105
precursor of p50), NFKB-2 (encoding the p100 precursor
of a 52 kD homologue of p50), relA (encoding p65), c-rel
and relB. All of these polypeptides can bind as homo-
dimers or heterodimers to consensus KB sequence motifs,
and all have been shown to affect transcription of KB-
containing reporter constructs positively or negatively in
transfection experiments. Previous work had indicated an
ordered appearance of NFKB/Rel complexes during B-
cell development: p5 0 and p65 dominate in pre-B and
non-B cells; p50 and Rel in mature B cells; and p52 and
RelB in plasma cells ([8] and references therein).
Despite a large body of correlative evidence suggesting a
critical role for p50 in early B-cell development,
homozygous disruption of the pO5 gene failed to perturb
the development of B or T cells [4]. The relB gene has
also been disrupted recently, without discernable effects
on lymphocyte development; relB-deficient mice do,
however, show a striking reduction in the numbers of
dendritic cells in the thymic medulla [17,18]. On the
other hand, p50 is clearly essential for normal immune
responses: p50/- mice exhibit a failure of B-cell prolifer-
ation in response to lipopolysaccharide, diminished pro-
duction of non-M immunoglobulin isotypes, diminished
T-cell-dependent production of immunoglobulins, and
failure of T-cell proliferation in response to crosslinking
of the T-cell antigen receptor to the co-stimulatory
molecule CD28 [4]. Overall, the phenotype of p 5O-
deficient mice would have been difficult to predict from
previous studies.
The role of E2A in hematopoiesis can be contrasted with
those of two other transcription factors, PU.1 and Ikaros.
Inactivation of PU.1 results in ablation of the granulo-
cytic, monocytic and lymphoid lineages, but leaves
megakaryoid and erythroid development intact [19].
PU.1 may act, therefore, at the level of a multipotent
granulocytic, lymphoid and myeloid progenitor cell.
Inactivation of Ikaros ablates the B- and T-lymphoid
compartments, but spares the development of all other
haematopoietic lineages [20]. This suggests that Ikaros
acts downstream of PU.1 to promote the differentiation
608 Current Biology 1995, Vol 5 No 6
of a multipotent progenitor into a component of the
lymphocyte pathways (Fig. 1). Both PU.1 and Ikaros
seem to act earlier in hematopoiesis than E2A, whose
disruption affects only the B lineage. As B- and T-cell
development are similar in many details, it will be inter-
esting to see whether there is a protein that, like E2A,
acts downstream of Ikaros but which is required
selectively for T-cell development.
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